Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Apr;18(4):414-415.
doi: 10.1016/S1470-2045(17)30172-9. Epub 2017 Mar 9.

A step forward for patients with NRAS-mutant melanoma

Michael A Postow  1 , Paul B Chapman  2
Affiliations
Comment

A step forward for patients with NRAS-mutant melanoma

Michael A Postow et al. Lancet Oncol. 2017 Apr.

Abstract

Steve Gschmeissner/Science Photo Library

PubMed Disclaimer

Comment on

References

    1. Cancer Genome Atlas N. Genomic Classification of Cutaneous Melanoma. Cell. 2015;161(7):1681–96. - PMC - PubMed
    1. Joseph EW, Pratilas CA, Poulikakos PI, et al. The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner. Proc Natl Acad Sci U S A. 2010;107(33):14903–8. - PMC - PubMed
    1. Ascierto PA, Schadendorf D, Berking C, et al. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. The Lancet Oncology. 2013;14(3):249–56. - PubMed
    1. Dougherty MK, Muller J, Ritt DA, et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell. 2005;17(2):215–24. - PubMed
    1. Tate SC, Burke TF, Hartman D, Kulanthaivel P, Beckmann RP, Cronier DM. Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours. Br J Cancer. 2016;114(6):669–79. - PMC - PubMed